Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context
暂无分享,去创建一个
A. Melegaro | C. Whittaker | O. Watson | P. Walker | A. Ghani | L. Okell | S. Gregson | N. Brazeau | W. MacLeod | E. Del Fava | L. Mwananyanda | G. Kwenda | L. Mulenga | J. Lungu | C. Moyo | R. Pieciak | J. Hines | C. Gill | Gregory Barnsley | Daniela Olivera Mesa | Ines Gerard-Ursin | Stephen Longa Chanda | D. Olivera Mesa | G. Barnsley | Richard J Sheppard | S. L. Chanda
[1] J. Wakefield,et al. The WHO estimates of excess mortality associated with the COVID-19 pandemic , 2022, Nature.
[2] D. Thea,et al. What is the prevalence of COVID-19 detection by PCR among deceased individuals in Lusaka, Zambia? A postmortem surveillance study , 2022, BMJ Open.
[3] Richard van Noorden. COVID death tolls: scientists acknowledge errors in WHO estimates , 2022, Nature.
[4] S. Bhatt,et al. Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling , 2022, Communications Medicine.
[5] Mohammed Al-Kassim Hassan,et al. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa , 2022, International journal of health services : planning, administration, evaluation.
[6] A. Nardone,et al. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021 , 2022, BMJ Global Health.
[7] L. London,et al. Unequal global vaccine coverage is at the heart of the current covid-19 crisis , 2021, BMJ.
[8] N. French,et al. SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021 , 2021, BMC Medicine.
[9] S. Madhi,et al. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey , 2021, International journal of epidemiology.
[10] M. Senthilingam. Covid-19: Why Africa’s pandemic is different , 2021, BMJ.
[11] Y. Gal,et al. Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe , 2021, Nature Communications.
[12] Andrew T. Levin,et al. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications , 2021, BMJ Global Health.
[13] M. Masika,et al. High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya , 2021, International Journal of Infectious Diseases.
[14] O. Planz,et al. COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway , 2021, Viruses.
[15] U. V. Ukah,et al. COVID-19 vaccine hesitancy in Africa: a scoping review , 2021, Global Health Research and Policy.
[16] A. Kaminga,et al. Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis , 2021, Reviews in medical virology.
[17] R. Wilf-Miron,et al. Tipping the scales: a theoretical model to describe the differential effects of the COVID-19 pandemic on mortality , 2021, International Journal for Equity in Health.
[18] A. Nakimuli,et al. Indirect effects of COVID-19 on maternal, neonatal, child, sexual and reproductive health services in Kampala, Uganda , 2021, BMJ Global Health.
[19] S. Bhatt,et al. Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria , 2021, Nature Communications.
[20] V. Rousson,et al. Estimating the basic reproduction number for COVID-19 in Western Europe , 2021, PloS one.
[21] S. Majumdar,et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker) , 2021, Nature Human Behaviour.
[22] Rachel E. Baker,et al. Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa , 2021, Nature Medicine.
[23] C. Mapoma,et al. Application of verbal autopsy in routine civil registration in Lusaka District of Zambia , 2021, BMC Health Services Research.
[24] L. Boudourakis,et al. Decreased COVID-19 Mortality-A Cause for Optimism. , 2020, JAMA internal medicine.
[25] J. West,et al. High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa , 2020, International Journal of Infectious Diseases.
[26] D. Cummings,et al. Age-specific mortality and immunity patterns of SARS-CoV-2 , 2020, Nature.
[27] Y. Lawal. Africa’s low COVID-19 mortality rate: A paradox? , 2020, International Journal of Infectious Diseases.
[28] A. Takada,et al. First COVID-19 case in Zambia — Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries , 2020, International Journal of Infectious Diseases.
[29] I. Elyazar,et al. Quantifying the dynamics of COVID-19 burden and impact of interventions in Java, Indonesia , 2020, medRxiv.
[30] M. Campbell,et al. Addressing Africa’s pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa , 2020, International Journal of Infectious Diseases.
[31] B. Smart,et al. COVID-19 in South Africa , 2020, Global Epidemiology.
[32] D. Normando,et al. Effects of temperature and humidity on the spread of COVID-19: A systematic review , 2020, PloS one.
[33] J. Bernstein,et al. COVID-19 pandemic: The African paradox , 2020, Journal of global health.
[34] R. Ke,et al. Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination , 2020, Journal of Theoretical Biology.
[35] J. Drake,et al. Reconciling model predictions with low reported cases of COVID-19 in Sub-Saharan Africa: insights from Madagascar , 2020, medRxiv.
[36] S. Bhatt,et al. State-level tracking of COVID-19 in the United States , 2020, Nature Communications.
[37] Hui Zhang,et al. Transmissibility of COVID-19 in 11 major cities in China and its association with temperature and humidity in Beijing, Shanghai, Guangzhou, and Chengdu , 2020, Infectious Diseases of Poverty.
[38] I. Osseni. COVID-19 pandemic in sub-Saharan Africa: preparedness, response, and hidden potentials , 2020, Tropical Medicine and Health.
[39] S. Bhatt,et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.
[40] B. Gunn,et al. Why is There Low Morbidity and Mortality of COVID-19 in Africa? , 2020, The American journal of tropical medicine and hygiene.
[41] M. Ngom,et al. The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study , 2020, BMJ Global Health.
[42] S. Merler,et al. Social Contact Structures and Time Use Patterns in the Manicaland Province of Zimbabwe , 2017, PloS one.